Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical δ-aminolevulinic acid photodynamic therapy

Archives of Dermatology

Volumn 134, Issue 7, 1998, Pages 821-826

  Fink Puches, Regina ^a   Soyer, Hans Peter ^a   Hofer, Angelika ^a   Kerl, Helmut ^a   Wolf, Peter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; AUSTRIA; BASAL CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OUTCOMES RESEARCH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TOPICAL DRUG ADMINISTRATION;

EID: 0031852118     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.7.821     Document Type: Article

References (32)

1. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;6:143-148.
2. Wolf P, Kerl H. Photodynamic therapy in patients with xeroderma pigmentosum. Lancet. 1991;337:1613-1614.
3. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical δ-aminolevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B. 1995;29:53-57.
4. Svanberg K, Anderson T, Kiliander D, et al. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical δ-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743-751.
5. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of δ-aminolevulinic acid: an alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol. 1993;28:17-21.
6. Wolf P, Kerl H. Photodynamic therapy with δ-aminolevulinic acid: a promising concept for the treatment of cutaneous tumors. Dermatology. 1996;190:183-185.
7. Fink-Puches R, Hofer A, Smolle J, Kerl H, Wolf P. Primary clinical response and long-term follow-up of solar keratoses treated with topically applied δ-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B. 1997;41:145-151.
8. Sachs L. Angewandte Statistik: Anwendung Statistischer Methoden. Berlin, Germany: Springer-Verlag; 1984.
9. Kopera D, Cerroni L, Fink-Puches R, Kerl H. Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol. 1996;34:937-939.
10. Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol. 1991;24:1002-1004.
11. Goette DK. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol. 1981;4:633-649.
12. Greenway HT, Cornell RC, Tanner DJ, Peets E, Bordin GM, Nagi C. Treatment of basal cell carcinomas with intralesional Interferon. J Am Acad Dermatol. 1986;15:437-443.
13. Chernosky ME. Squamous cell and basal cell carcinomas: preliminary study of 3817 primary skin cancers. South Med J. 1978;71:802-803.
14. Marchac D, Papadopoulos O, Duport G. Curative and aesthetic results of surgical treatment of 138 basal cell carcinomas. J Dermatol Surg Oncol. 1982;8:379-387.
15. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas, III: surgical excision. J Dermatol Surg Oncol. 1993;19:175-176.
16. Mohs FE. Chemosurgery: a microscopically controlled surgery for skin cancer - past, present, and future. J Dermatol Surg Oncol. 1978;4:41-54.
17. Reymann F. Basal cell carcinoma of the skin: recurrence rate of different types of treatment. Dermatologica. 1980;161:217-226.
18. Litwin MS, Ryan RF, Ichinose H. Use of 5-fluorouracil in topical therapy of skin cancer: a review of 157 patients. Proc Natl Cancer Conf. 1972;7:549-561.
19. Stoll HL, Klein E, Case RW. Tumors of the skin, VII: effects of varying the concentration of locally administered 5-fluorouracil on basal cell carcinomas. J Invest Dermatol. 1967;49:219-224.
20. Ikic D, Spaventi S, Belicza M. Interferon reduces recurrences of basal cell and squamous cell cancers. Int J Dermatol. 1995;34:58-60.
21. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX: a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14:275-293.
22. Wennberg A-M, Lindholm L-E, Alpsten M, Larkö O. Treatment of superficial basal cell carcinomas using topically applied δ-aminolevulinic acid and a filtered xenon lamp. Arch Dermatol Res. 1996;288:561-564.
23. Lui H, Salasche S, Kollias N, et al. Photodynamic therapy of nonmelanoma skin cancer with topical δ-aminolevulinic acid: a clinical and histological study. Arch Dermatol. 1995;131:737-738.
24. Cairnduff F, Stringer MR, Hudson EJ, Ash DV, Brown SB. Superficial photodynamic therapy with topical δ-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer. 1994;69:605-608.
25. Martin A, Tope WD, Grevelink JM, et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of δaminolevulinic acid: implications for photodynamic treatment. Arch Dermatol. Res. 1995;287:665-674.
26. Wolf P. Photodynamische Therapie. Hautarzt. 1997;48:137-148.
27. Bickers DR, Pathak MA, Lim HW. The porphyrias. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in General Medicine. New York, NY: McGraw-Hill Book Co; 1993:1854-1893.
28. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol. 1995;35:83-90.
29. Canney PA, Dean ST. Transforming growth factor β: a promoter of late connective tissue injury following radiotherapy? Br J Radiol. 1990;63:620-623.
30. 1 as a signal for induction of cell death by apoptosis. Br J Cancer. 1993;67:531-536.
31. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using δ-aminolevulinic acid and desferrioxamine. Br J Dermatol. 1995;133:282-288.
32. Fink-Puches R, Wolf P, Kerl H. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol. 1997;133:1494-1495.